Niramas Utama Tbk. vs Kalbe Farma Tbk — how do they compare? Niramas Utama Tbk. trades at Rp635 (market cap 848.22B, 10.75M 24h volume), while Kalbe Farma Tbk trades at Rp800 (market cap 37.45T, 41.79M 24h volume). The key difference: Kalbe Farma Tbk is far larger — about 44.2× Niramas Utama Tbk.'s market cap, and Kalbe Farma Tbk is more actively traded (41.79M versus 10.75M). Which is the better fit depends on your goals.
| JELI | KLBF | |
|---|---|---|
Market Cap | 848.22B | 37.45T |
Volume | 10.75M | 41.79M |
Lot | 107.48K | 417.89K |
Turnover | 6.9B | 33.46B |
Average Price | 642.24 | 800.79 |
Value | 6.9B | 33.46B |
Indicative Equilibrium Price | 635 | 800 |
Indicative Equilibrium Volume | 6.4K | 18.3K |
Trailing returns across standard periods
Latest headlines on both assets
PT. Niramas Utama Tbk. (the Company) formerly PT Nata Sari Raya was established based on Notarial Deed No. 86 dated 22 November 1990, by Notary Samsul Hadi, S.H. The Company started its commercial operations in 1994. The parent entity and the ultimate parent entity of the Company are PT Niramas Utama International and PT Supra Sentral Investama
Read more on JELI →PT Kalbe Farma Tbk (the Company) was established in the Republic of Indonesia, within the framework of the Domestic Capital Investment Law No. 6 Year 1968, as amended by Law No. 12 Year 1970, basedon Notarial Deed No. 3 of Raden Imam Soesetyo Prawirokoesoemo datedon September 10th, 1966. The Company, which started commercial operation in 1966.
Read more on KLBF →